- Home
- OGI vs CBUS Comparison
OGI vs CBUS Comparison
Compare OGI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- CBUS
- Stock Information
- Founded
- OGI 2013
- CBUS 2010
- Country
- OGI Canada
- CBUS United States
- Employees
- OGI N/A
- CBUS N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- OGI Health Care
- CBUS Industrials
- Exchange
- OGI Nasdaq
- CBUS Nasdaq
- Market Cap
- OGI 176.1M
- CBUS 160.8M
- IPO Year
- OGI N/A
- CBUS 2017
- Fundamental
- Price
- OGI $1.97
- CBUS $4.93
- Analyst Decision
- OGI
- CBUS Strong Buy
- Analyst Count
- OGI 0
- CBUS 3
- Target Price
- OGI N/A
- CBUS $23.67
- AVG Volume (30 Days)
- OGI 424.2K
- CBUS 141.8K
- Earning Date
- OGI 08-13-2024
- CBUS 11-07-2024
- Dividend Yield
- OGI N/A
- CBUS N/A
- EPS Growth
- OGI N/A
- CBUS N/A
- EPS
- OGI N/A
- CBUS N/A
- Revenue
- OGI $110,297,722.00
- CBUS $2,961,000.00
- Revenue This Year
- OGI $8.76
- CBUS $36.93
- Revenue Next Year
- OGI $14.04
- CBUS $236.45
- P/E Ratio
- OGI N/A
- CBUS N/A
- Revenue Growth
- OGI 2.33
- CBUS 816.72
- 52 Week Low
- OGI $0.97
- CBUS $4.26
- 52 Week High
- OGI $2.91
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- OGI 57.16
- CBUS 36.94
- Support Level
- OGI $1.76
- CBUS $4.77
- Resistance Level
- OGI $1.92
- CBUS $5.58
- Average True Range (ATR)
- OGI 0.08
- CBUS 0.62
- MACD
- OGI -0.00
- CBUS 0.03
- Stochastic Oscillator
- OGI 95.00
- CBUS 29.57
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.